Orthopaedic Oncology Service

COVID-19 and SAFE CARE COMMITMENT

Mass General Orthopaedics is committed to serving our current and new patients throughout the course of the COVID-19 pandemic. We have largely resumed routine operations, and we are available to answer and address any concerns you may have. Please read more about Mass General’s Safe Care Commitment and the steps being taken to ensure the safety and well-being of all patients, clinicians and staff.

In-Person Clinical Care

The Orthopaedic Oncology Service has resumed all in-person appointments. You can reach out to your surgeon’s office directly with questions about missed appointments or scheduling a new appointment.

Virtual Care Visit

All patients (NEW or ESTABLISHED) can make a virtual visit appointment or phone call with our providers. Call 617-724-3700 or call one of our surgeons’ offices directly. The virtual visit is a good way to evaluate new injuries or recurrent pain, and check-in with your provider about your current condition. Discussions about surgical options also can begin in this environment. New patients must register (1-866-211-6588) before an any appointment can be made. You must enroll in Patient Gateway in order to have a virtual visit.

Surgery

The Department of Orthopaedic Surgery has resumed all surgeries. If you have questions about a surgery that was postponed, speak to your surgeon’s office.

We want you to know that your Orthopaedic Oncology surgeons (Raskin, Lozano, Newman), DNP Fiore, Medical Oncologists (Choy, Cote), Radiation Oncologists (Delaney, Chen) and Surgical Oncologist (Mullen) remain with you and your family during this COVID-19 emergency. We are all available to answer/address any concerns you may have.

We appreciate your patience and understanding as we all proceed together through this COVID-19 situation.


Compassionate, Multidisciplinary Treatment

For more than 45 years, the Mass General Orthopaedic Oncology Service has treated children, adolescents and adults with primary bone and soft tissue tumors (benign and malignant) and metastatic disease.

Bone and soft tissue sarcomas are among the rarest malignant tumors treated. There are approximately 3,000 new cases of primary bone tumors each year, which accounts for less than 0.2% of all adult cancer cases. And there are approximately 13,000 new primary soft tissue tumors each year, which account for 1% of all adult cancer cases. Because of this, we take a comprehensive approach to treating these rare tumors, incorporating every resource the hospital has to offer to ensure our patients receive the best and most current treatment available.

Treatment plans are coordinated through our team approach and includes orthopaedic oncology surgeons, radiation oncologists, medical oncologists, pathologists, radiologists and nurse practitioners. Medical and surgical experts work together seamlessly to provide treatment programs that are individually designed for each patient. We carefully assess outcomes and take pride in making it possible for our patients to live their lives as fully as possible.



Patient Resources

An icon representing patient resources
Conditions & Treatments

Conditions & Treatments

Our comprehensive patient education hub created by our clinicians for our patients.

An icon representing research
Harris Center for Chordoma Care

Harris Center for Chordoma Care

A multidisciplinary center created to support chordoma patients.

An icon representing patient education
ICAN: Amputee Network

ICAN: Amputee Network

A new collaboration with orthopaedic surgeons, plastic surgeons and rehab specialists.